Home LiteratureArticle Details
PMID: 16998187 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

NMR solution structure of the major G-quadruplex structure formed in the human BCL2 promoter region.

Nucleic acids research ·Vol. 34 ·No. 18 ·2006-00-00 ·Pages 5133-44

Dai J, Chen D, Jones RA, Hurley LH, Yang D

Abstract

BCL2 protein functions as an inhibitor of cell apoptosis and has been found to be aberrantly expressed in a wide range of human diseases. A highly GC-rich region upstream of the P1 promoter plays an important role in the transcriptional regulation of BCL2. Here we report the NMR solution structure of the major intramolecular G-quadruplex formed on the G-rich strand of this region in K+ solution. This well-defined mixed parallel/antiparallel-stranded G-quadruplex structure contains three G-tetrads of mixed G-arrangements, which are connected with two lateral loops and one side loop, and four grooves of different widths. The three loops interact with the core G-tetrads in a specific way that defines and stabilizes the overall G-quadruplex structure. The loop conformations are in accord with the experimental mutation and footprinting data. The first 3-nt loop adopts a lateral loop conformation and appears to determine the overall folding of the BCL2 G-quadruplex. The third 1-nt double-chain-reversal loop defines another example of a stable parallel-stranded structural motif using the G3NG3 sequence. Significantly, the distinct major BCL2 promoter G-quadruplex structure suggests that it can be specifically involved in gene modulation and can be an attractive target for pathway-specific drug design.

MeSH Terms
DNA/chemistry DNA Mutational Analysis G-Quadruplexes Genes, bcl-2 Guanine/chemistry Humans Models, Molecular Mutation Nuclear Magnetic Resonance, Biomolecular Nucleic Acid Conformation Phosphorus/chemistry Promoter Regions, Genetic Protons Solutions Transcription, Genetic
Chemicals
Protons Solutions Phosphorus Guanine DNA
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Dai Jixun
College of Pharmacy, The University of Arizona, 1703 E. Mabel Street, Tucson, AZ 85721, USA.
Chen Ding
Jones Roger A
Hurley Laurence H
Yang Danzhou
References (53)
53 references, click to expand
  1. Genetic redox preconditioning differentially modulates AP-1 and NF kappa B responses following cardiac ischemia/reperfusion injury and protects against necrosis and apoptosis.
    Mol Ther. 2003 Mar;7(3):341-53 PMID: 12668130
  2. Human telomeric sequence forms a hybrid-type intramolecular G-quadruplex structure with mixed parallel/antiparallel strands in potassium solution.
    Nucleic Acids Res. 2006;34(9):2723-35 PMID: 16714449
  3. Gene therapy and hypothermia for stroke treatment.
    Ann N Y Acad Sci. 2003 May;993:54-68; discussion 79-81 PMID: 12853295
  4. The dynamic character of the G-quadruplex element in the c-MYC promoter and modification by TMPyP4.
    J Am Chem Soc. 2004 Jul 21;126(28):8702-9 PMID: 15250722
  5. Propeller-type parallel-stranded G-quadruplexes in the human c-myc promoter.
    J Am Chem Soc. 2004 Jul 21;126(28):8710-6 PMID: 15250723
  6. A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumors.
    Ann Oncol. 2004 Aug;15(8):1274-83 PMID: 15277270
  7. Novel DNA bis-intercalation by MLN944, a potent clinical bisphenazine anticancer drug.
    J Biol Chem. 2004 Oct 29;279(44):46096-103 PMID: 15317822
  8. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.
    Proc Natl Acad Sci U S A. 1986 Jul;83(14):5214-8 PMID: 3523487
  9. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.
    Cell. 1986 Oct 10;47(1):19-28 PMID: 2875799
  10. Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma.
    EMBO J. 1988 Jan;7(1):123-31 PMID: 2834197
  11. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.
    Proteins. 1991;11(4):281-96 PMID: 1758883
  12. The human insulin gene linked polymorphic region exhibits an altered DNA structure.
    Nucleic Acids Res. 1992 Jan 25;20(2):231-6 PMID: 1741248
  13. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.
    Cancer Res. 1992 Dec 15;52(24):6940-4 PMID: 1458483
  14. A negative regulatory element in the bcl-2 5'-untranslated region inhibits expression from an upstream promoter.
    Mol Cell Biol. 1993 Jun;13(6):3686-97 PMID: 8388542
  15. bcl-2 protein in non-small-cell lung carcinoma.
    N Engl J Med. 1993 Sep 2;329(10):690-4 PMID: 8393963
  16. Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines.
    Ann Oncol. 1994;5 Suppl 1:61-5 PMID: 8172820
  17. Expression of Bcl-2 protein and Bcl-2 mRNA in normal and neoplastic lymphoid tissues.
    Leuk Lymphoma. 1994 Mar;13(1-2):81-7 PMID: 8025526
  18. Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-tetraplex.
    Structure. 1993 Dec 15;1(4):263-82 PMID: 8081740
  19. Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat.
    J Am Soc Nephrol. 2000 Mar;11(3):454-67 PMID: 10703669
  20. Unusual DNA structure of the diabetes susceptibility locus IDDM2 and its effect on transcription by the insulin promoter factor Pur-1/MAZ.
    Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12508-12 PMID: 11070077
  21. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3.
    Nat Cell Biol. 2001 Feb;3(2):183-91 PMID: 11175751
  22. Investigation of unusual DNA motifs.
    Methods Enzymol. 2001;338:341-71 PMID: 11460557
  23. Molecular recognition of DNA by small molecules.
    Bioorg Med Chem. 2001 Sep;9(9):2215-35 PMID: 11553460
  24. Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2.
    Cancer Res. 2001 Sep 15;61(18):6693-7 PMID: 11559537
  25. Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening.
    J Med Chem. 2001 Dec 6;44(25):4313-24 PMID: 11728179
  26. NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
    Oncogene. 2002 May 30;21(24):3898-908 PMID: 12032828
  27. Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment.
    Antisense Nucleic Acid Drug Dev. 2002 Jun;12(3):193-213 PMID: 12162702
  28. Apoptosis and muscle fibre loss in neuromuscular disorders.
    Neuromuscul Disord. 2002 Oct;12(7-8):613-22 PMID: 12207928
  29. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription.
    Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11593-8 PMID: 12195017
  30. Bcl-2 protein expression and long-term survival in breast cancer.
    Am J Pathol. 1994 Nov;145(5):1191-8 PMID: 7977649
  31. Anticancer drug resistance and inhibition of apoptosis.
    Anticancer Res. 1994 Nov-Dec;14(6A):2291-4 PMID: 7825961
  32. The chicken beta-globin gene promoter forms a novel "cinched" tetrahelical structure.
    J Biol Chem. 1996 Mar 1;271(9):5208-14 PMID: 8617804
  33. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
    Cancer. 1996 Jan 15;77(2):255-64 PMID: 8625232
  34. CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas.
    J Biol Chem. 1996 Sep 13;271(37):22687-91 PMID: 8798441
  35. The WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomas.
    J Biol Chem. 1997 Aug 1;272(31):19609-14 PMID: 9235968
  36. To die or not to die: an overview of apoptosis and its role in disease.
    JAMA. 1998 Jan 28;279(4):300-7 PMID: 9450715
  37. Expression of bcl-2 in invasive and in situ carcinoma of the uterine cervix.
    Am J Obstet Gynecol. 1998 Jan;178(1 Pt 1):113-7 PMID: 9465813
  38. DNA tetraplex formation in the control region of c-myc.
    Nucleic Acids Res. 1998 Mar 1;26(5):1167-72 PMID: 9469822
  39. BCL-2 family: regulators of cell death.
    Annu Rev Immunol. 1998;16:395-419 PMID: 9597135
  40. The Bcl-2 protein family: arbiters of cell survival.
    Science. 1998 Aug 28;281(5381):1322-6 PMID: 9735050
  41. Sequence-specific DNA minor groove binders. Design and synthesis of netropsin and distamycin analogues.
    Bioconjug Chem. 1998 Sep-Oct;9(5):513-38 PMID: 9736486
  42. Activation of the Bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade.
    Nucleic Acids Res. 1999 May 15;27(10):2086-90 PMID: 10219080
  43. Solution structure of the biologically relevant G-quadruplex element in the human c-MYC promoter. Implications for G-quadruplex stabilization.
    Biochemistry. 2005 Feb 15;44(6):2048-58 PMID: 15697230
  44. Formation and properties of hairpin and tetraplex structures of guanine-rich regulatory sequences of muscle-specific genes.
    Nucleic Acids Res. 2005;33(9):2887-900 PMID: 15908587
  45. An inhibitor of Bcl-2 family proteins induces regression of solid tumours.
    Nature. 2005 Jun 2;435(7042):677-81 PMID: 15902208
  46. Homodimeric MyoD preferentially binds tetraplex structures of regulatory sequences of muscle-specific genes.
    J Biol Chem. 2005 Jul 22;280(29):26805-12 PMID: 15923190
  47. Structure, internal motions and association-dissociation kinetics of the i-motif dimer of d(5mCCTCACTCC).
    Nucleic Acids Res. 2005;33(17):5471-81 PMID: 16204453
  48. Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents.
    Nucleic Acids Res. 2005;33(18):6070-80 PMID: 16239639
  49. Evidence for the presence of a guanine quadruplex forming region within a polypurine tract of the hypoxia inducible factor 1alpha promoter.
    Biochemistry. 2005 Dec 13;44(49):16341-50 PMID: 16331995
  50. (3 + 1) Assembly of three human telomeric repeats into an asymmetric dimeric G-quadruplex.
    J Am Chem Soc. 2005 Dec 14;127(49):17277-85 PMID: 16332077
  51. An intramolecular G-quadruplex structure with mixed parallel/antiparallel G-strands formed in the human BCL-2 promoter region in solution.
    J Am Chem Soc. 2006 Feb 1;128(4):1096-8 PMID: 16433524
  52. Deconvoluting the structural and drug-recognition complexity of the G-quadruplex-forming region upstream of the bcl-2 P1 promoter.
    J Am Chem Soc. 2006 Apr 26;128(16):5404-15 PMID: 16620112
  53. Role of the bcl-2 gene after contusive spinal cord injury in mice.
    Neurosurgery. 2003 Jul;53(1):192-8; discussion 198 PMID: 12823889
Article Info
Journal
Nucleic acids research
Abbr.
Nucleic Acids Res
ISSN
1362-4962
Published
2006-00-00
Epub
2006-00-22
Pages
5133-44
Language
English
Region
England
NLM ID
0411011
PMCID
PMC1636422
Subset
IM
Grants
NCI NIH HHS · K01 CA083886 · United States
NCI NIH HHS · 1K01CA83886 · United States
NCRR NIH HHS · 1S10 RR16659 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com